Clin2
NCT06667934Possibly a fitNot yet recruiting

Zuoqing SAN herbal medicine for ulcerative colitis

Ulcerative Colitis (UC)

Part of Digestive system clinical trials.

This trial tests a Chinese herbal medicine called Zuoqing SAN for treating mild to moderate ulcerative colitis. It aims to see if it can help reduce inflammation and improve symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of ulcerative colitis.
  • Your ulcerative colitis is mild to moderate, not severe.
  • You do not have severe liver, kidney, heart, or brain disease.
  • You are not allergic to any Chinese herbal medicines.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06725017Not yet recruiting· Phase 2
Live bacteria powder for ulcerative colitis

This trial tests a live bacteria powder (SK08) taken by mouth for ulcerative colitis. It aims to see if the bacteria can reduce inflammation and improve symptoms. You may qualify if standard treatments haven't worked well for you.

NCT07411131Not yet recruiting
Synbiotic supplement for mild ulcerative colitis

This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.

Hong Kong
NCT07650942Not yet recruiting· Phase 3
Study drug for moderate to severe ulcerative colitis

This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.

Guangzhou
NCT07335055Recruiting· Phase 2
Testing HSK47388 for moderate to severe ulcerative colitis

This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.

Hangzhou
NCT07820046Not yet recruiting· Phase 2/Phase 3
Nitazoxanide added to usual care for mild-to-moderate ulcerative colitis

This study tests whether adding nitazoxanide, an anti-parasitic medicine, to your current ulcerative colitis treatment helps reduce inflammation and symptoms. It may offer an extra option for people with mild-to-moderate disease.

NCT07786389Enrolling by invitation· Phase 1/Phase 2
Seaweed supplement for ulcerative colitis inflammation

This study tests whether a supplement made from seaweed (fucoidan) can help reduce gut inflammation in people with mild to moderate ulcerative colitis. If you join, you'll take the supplement and have your symptoms and blood levels checked.

Lahore, Punjab Province

Hear when a new Ulcerative Colitis (UC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.